🔗 Permalink

Inventor profile of:

Jeffrey D. Johnson

City:

Moraga, California

Country:

United States

Published Applications:

Last publication date:

2018-01-25

Top Assignees for applications by Jeffrey D. Johnson

The entities that hold a legal rights for patent applications filed by inventor Johnson Jeffrey D.:

Metabolex, Inc. 18 Hayward, CA United States
CymaBay Therapeutics, Inc. 6 Newark, CA United States

Recent patent applications by Johnson Jeffrey D.

Jeffrey D. Johnson from Moraga, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-01-25

US20180021335A1

Human necessities

Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

#2 | 2017-04-20

US20170105993A1

Human necessities

Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

#3 | 2015-08-27

US20150239881A1

Chemistry; metallurgy

HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS

#4 | 2014-01-23

US20140024830A1

Chemistry; metallurgy

Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

#5 | 2013-10-24

US20130281691A1

Chemistry; metallurgy

Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

#6 | 2013-03-07

US20130059856A1

Chemistry; metallurgy

Agonists of GPR131 and uses thereof

#7 | 2010-05-27

US20100130511A1

Human necessities

Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

#8 | 2010-04-08

US20100087465A1

Human necessities

2,4-disubsituted thiazoles and pharmaceutical compositions thereof

#9 | 2009-02-26

US20090054475A1

Human necessities

5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine

#10 | 2008-12-25

US20080318312A1

Chemistry; metallurgy

PANCREATIC ISLET TRANSCRIPTION FACTOR AND USES THEREOF

#11 | 2008-10-09

US20080248010A1

Chemistry; metallurgy

Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)

#12 | 2008-03-13

US20080064857A1

Electricity

Methods and Reagents for Diagnosis and Treatment of Diabetes

#13 | 2007-03-08

US20070055050A1

Chemistry; metallurgy

Methods and reagents for diagnosis and treatment of diabetes

#14 | 2007-02-08

US20070031897A1

Chemistry; metallurgy

Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRP

#15 | 2006-12-05

US10308393

Methods and reagents for diagnosis and treatment of diabetes

#16 | 2006-11-23

US20060264611A1

Chemistry; metallurgy

Pancreatic islet transcription factor and uses thereof

#17 | 2006-11-09

US20060252100A1

Chemistry; metallurgy

Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)

#18 | 2006-11-02

US20060246006A1

Physics

CD39L3 and its role in diabetes

#19 | 2006-08-08

US10794897

Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRP

#20 | 2006-07-06

US20060148037A1

Physics

Polynucleotides encoding an isolated β-islet cell two-pore domain potassium channel

#21 | 2006-05-30

US10459190

Isolated islet beta-cell two-pore domain potassium channel

#22 | 2005-10-20

US20050233347A1

Chemistry; metallurgy

Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)

#23 | 2005-09-22

US20050208516A1

Chemistry; metallurgy

Methods and reagents for diagnosis and treatment of diabetes

#24 | 2005-08-25

US20050186582A1

Physics

Compositions and methods of using hexokinase V

InventorID:

129029 ⎘